Upstream Medical Technologies Ltd (UMT) is a biomarker based testing developer that markets novel biomarkers for cardiac diagnosis. The company offers patented pipeline of products such as BNP-sp, used for diagnoses of unstable angina, CVD, ACS, and others. It provides pipe line product such as Ghr-sp-Pne diagnoses heart failure in the presence of pneumonia; and EPO-sp for detection of kidney failure. It offers products to identify comorbid disease associated with kidney failure, metabolic disease, sepsis and atrial fibrillation, among others. The company develops biomarker-based testing for diagnoses of heart disease and associated clinical complications. UMT is headquartered in Christchurch, New Zealand.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Upstream Medical Technologies Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Upstream Medical Technologies Ltd Company Overview
- Upstream Medical Technologies Ltd Company Snapshot
- Upstream Medical Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Upstream Medical Technologies Ltd - Pipeline Analysis Overview
- Upstream Medical Technologies Ltd - Key Facts
- Upstream Medical Technologies Ltd - Major Products and Services
- Upstream Medical Technologies Ltd Pipeline Products by Development Stage
- Upstream Medical Technologies Ltd Pipeline Products Overview
- CNP-sp Test - Heart Disease
- CNP-sp Test - Heart Disease Product Overview
- CRP-sp Assay - Heart Failure
- CRP-sp Assay - Heart Failure Product Overview
- EPO-sp Test
- EPO-sp Test Product Overview
- GH Assay - Heart Failure
- GH Assay - Heart Failure Product Overview
- Ghr-sp Test - Heart Disease
- Ghr-sp Test - Heart Disease Product Overview
- Ghr-sp-Pne Test - Heart Failure
- Ghr-sp-Pne Test - Heart Failure Product Overview
- IGFs Assay - Heart Failure
- IGFs Assay - Heart Failure Product Overview
- INS-sp Test - Heart failure
- INS-sp Test - Heart failure Product Overview
- KIM-1sp Assay - Heart Failure
- KIM-1sp Assay - Heart Failure Product Overview
- NGAL-sp Test - Heart Failure
- NGAL-sp Test - Heart Failure Product Overview
- PSA-sp Assay - Heart Failure
- PSA-sp Assay - Heart Failure Product Overview
- TnTuORF Test - Acute Coronary Syndrome
- TnTuORF Test - Acute Coronary Syndrome Product Overview
- TSH Assay - Heart Failure
- TSH Assay - Heart Failure Product Overview
- UARatio Test - Angina
- UARatio Test - Angina Product Overview
- Upstream Medical Technologies Ltd - Key Competitors
- Upstream Medical Technologies Ltd - Key Employees
- Upstream Medical Technologies Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Upstream Medical Technologies Ltd, Recent Developments
- May 15, 2017: Upstream Medical Technologies Provides Update on UARatio Test - Angina
- Jul 08, 2016: Upstream Medical Technologies: Dr Jim Januzzi accepts appointment to Scientific Advisory Board
- Jun 02, 2016: Professor Mark Richards accepts appointment to Scientific Advisory Board of Upstream Medical Technologies
- Oct 28, 2015: Breakthrough Medical Research Company Formed
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Upstream Medical Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Upstream Medical Technologies Ltd Pipeline Products by Equipment Type
- Upstream Medical Technologies Ltd Pipeline Products by Indication
- Upstream Medical Technologies Ltd, Key Facts
- Upstream Medical Technologies Ltd, Major Products and Services
- Upstream Medical Technologies Ltd Number of Pipeline Products by Development Stage
- Upstream Medical Technologies Ltd Pipeline Products Summary by Development Stage
- CNP-sp Test - Heart Disease - Product Status
- CNP-sp Test - Heart Disease - Product Description
- CRP-sp Assay - Heart Failure - Product Status
- CRP-sp Assay - Heart Failure - Product Description
- EPO-sp Test - Product Status
- EPO-sp Test - Product Description
- GH Assay - Heart Failure - Product Status
- GH Assay - Heart Failure - Product Description
- Ghr-sp Test - Heart Disease - Product Status
- Ghr-sp Test - Heart Disease - Product Description
- Ghr-sp-Pne Test - Heart Failure - Product Status
- Ghr-sp-Pne Test - Heart Failure - Product Description
- IGFs Assay - Heart Failure - Product Status
- IGFs Assay - Heart Failure - Product Description
- INS-sp Test - Heart failure - Product Status
- INS-sp Test - Heart failure - Product Description
- KIM-1sp Assay - Heart Failure - Product Status
- KIM-1sp Assay - Heart Failure - Product Description
- NGAL-sp Test - Heart Failure - Product Status
- NGAL-sp Test - Heart Failure - Product Description
- PSA-sp Assay - Heart Failure - Product Status
- PSA-sp Assay - Heart Failure - Product Description
- TnTuORF Test - Acute Coronary Syndrome - Product Status
- TnTuORF Test - Acute Coronary Syndrome - Product Description
- TSH Assay - Heart Failure - Product Status
- TSH Assay - Heart Failure - Product Description
- UARatio Test - Angina - Product Status
- UARatio Test - Angina - Product Description
- Upstream Medical Technologies Ltd, Key Employees
- Glossary
- Upstream Medical Technologies Ltd Pipeline Products by Equipment Type
- Upstream Medical Technologies Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Caldera Health Ltd
- Jackson Allison Medical & Surgical Ltd
- AROTEC Diagnostics Ltd
